Sterility testing is a core analytical competence at 3PBIOVIAN, with nearly three decades of experience analysing a wide range of product types, including protein‑based and viral products.
Read more
3PBIOVIAN provides end-to-end CDMO services for animal health, supporting the development and GMP manufacturing of veterinary vaccines and biologics. With proven expertise in recombinant proteins, vir...
Read more
3PBIOVIAN and the Colombia INC has signed a contract to carry out the development of a biosimilar monoclonal antibody (mAb) for an oncology indication, marking the first biosimilar mAb to be developed...
Read more
Adenoviruses have long been key players in gene therapy, enabling the delivery of genetic material to target cells. However, their strong immunogenicity and ability to infect multiple tissues have lim...
Read more
3PBIOVIAN strengthens its international R&D positioning with French CIR certification at its sites in Spain and Finland
Read more
In today’s rapidly evolving biopharmaceutical landscape, selecting the right Contract Development and Manufacturing Organization (CDMO) is one of the most strategic decisions a company can make. Whe...
Read more
3PBIOVIAN, a company specialized in the development and manufacturing of biological medicines for third parties, and Universidad CEU San Pablo in Madrid have signed a Business Collaboration Agreement ...
Read more
A consortium formed by the Clínica Universidad de Navarra, the Hospital Universitario de Navarra, the University of Navarra, the research centers FIMA and Navarrabiomed, and the technology companies ...
Read more
Analytical services are critical to the development and manufacture of safe and effective biopharmaceuticals. These analytical services often are outsourced to third-party laboratories, and in some ca...
Read more
Although operating under GMP standards is time-consuming and resource-intensive compared to working in a research setting, it is necessary for patient safety. These legally enforced GMP regulations re...
Read more
AAVion®, a fully integrated AAV manufacturing platform designed to accelerate gene therapy development. A ready-to-use Plasmid Platform intended to meet the increasing demand for plasmid DNA
Read more
Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform, and 3PBIOVIAN, a leading contract development and manufacturing organization (CDMO), announ...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
The study analyses the role of PARP2 protein in tumour development and...
